- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | Alps Group Inc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.08. | Alps Group Inc GAAP EPS of -$0.02, revenue of $4.9M | 3 | Seeking Alpha | ||
| 07.08. | Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update | 1.776 | GlobeNewswire (Europe) | Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global... ► Artikel lesen | |
| 06.08. | Alps Group Inc - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 24.06. | Why Did Alps Group (ALPS) Stock Jump Over 15% After Hours? | 2 | Benzinga.com | ||
| 23.06. | Alps Group Inc - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| ALPS GROUP Aktie jetzt für 0€ handeln | |||||
| 23.06. | Alps Group enters precision oncology via PDO research pact | 1 | Investing.com | ||
| 23.06. | Alps Group steigt mit Forschungspakt in die Präzisionsonkologie ein | 1 | Investing.com Deutsch | ||
| 23.06. | Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia | 1 | GlobeNewswire (USA) | ||
| 09.06. | Alps Group Inc - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 09.06. | Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022 | 2 | GlobeNewswire (USA) | ||
| 19.05. | Alps Group receives Nasdaq notice over minimum bid price deficiency | 2 | Seeking Alpha | ||
| 19.05. | Alps Group Inc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.05. | Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 222 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology... ► Artikel lesen | |
| 17.04. | Alps Group Inc: Alps Group Appoints Former Ernst &; Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight | 3 | GlobeNewswire (USA) | ||
| 17.04. | Alps Group Inc - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy | 247 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology... ► Artikel lesen | |
| 31.10.25 | Alps Group Inc: Alps Announces Closing of Business Combination with Globalink Investment Inc. | 699 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 55,85 | -0,03 % | Here's What Lifted BrightSpring Health Services (BTSG) | ||
| ALIGNMENT HEALTHCARE | 8,310 | -0,24 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| HEARTFLOW | 50,37 | +0,08 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,430 | -0,07 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| FRESENIUS | 45,210 | +0,24 % | EQS-News: mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars | EQS-News: mAbxience
/ Schlagwort(e): Vereinbarung/Sonstiges
mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars
19.09.2026... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,685 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| GENEDX | 97,78 | -0,05 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PROGYNY | 26,865 | +0,02 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BILLIONTOONE | 103,78 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,680 | -0,76 % | Siemens Healthineers Aktie: Unscharfes Selbstbild - Warren Wise Podcast | Scharfe Bilder für andere, ein unscharfes Bild von sich selbst. Siemens Healthineers baut die Technik, mit der Ärzte Krankheiten erkennen, sichtbar machen und behandeln - vom Bluttest über den großen... ► Artikel lesen | |
| BETA BIONICS | 22,020 | -0,09 % | Beta Bionics, Inc.: Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock | IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 19,540 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 18,500 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ADAPTHEALTH | 5,750 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| MIMEDX | 4,810 | 0,00 % | Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 |
Das Unternehmen ALPS GROUP INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,002 (-0,38 %) liegt der Kurs bei 0,399 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPS GROUP INC finden Sie auf Wallstreet Online.